Mbx Biosciences Inc (MBX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2025 | 12-2024 | 09-2024 | 06-2024 | 03-2024 | |
| Operating Expenses | 26,529 | 18,610 | 19,612 | 16,658 | 13,314 |
| Operating Income | -26,529 | -18,610 | -19,612 | -16,658 | -13,314 |
| Other Income | 2,649 | 3,024 | 1,470 | 801 | 977 |
| Pre-tax Income | -23,880 | -15,586 | -18,142 | -15,857 | -12,337 |
| Net Income Continuous | -23,880 | -15,586 | -18,142 | -15,857 | -12,337 |
| Net Income | $-23,880 | $-15,586 | $-18,142 | $-15,857 | $-12,337 |
| EPS Basic Total Ops | -0.71 | 19.84 | -2.78 | -12.62 | -10.26 |
| EPS Basic Continuous Ops | -0.71 | 19.84 | -2.78 | -12.62 | -10.26 |
| EPS Diluted Total Ops | -0.71 | 19.84 | -2.78 | -12.62 | -10.26 |
| EPS Diluted Continuous Ops | -0.71 | 19.84 | -2.78 | -12.62 | -10.26 |
| EPS Diluted Before Non-Recurring Items | -0.71 | -0.47 | -2.78 | N/A | N/A |
| EBITDA(a) | $-26,452 | $-18,552 | $-19,537 | $-16,595 | $-13,266 |